Glen Reid

9.8k total citations · 2 hit papers
110 papers, 7.1k citations indexed

About

Glen Reid is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Glen Reid has authored 110 papers receiving a total of 7.1k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Pulmonary and Respiratory Medicine, 41 papers in Molecular Biology and 28 papers in Oncology. Recurrent topics in Glen Reid's work include Occupational and environmental lung diseases (52 papers), MicroRNA in disease regulation (22 papers) and Drug Transport and Resistance Mechanisms (17 papers). Glen Reid is often cited by papers focused on Occupational and environmental lung diseases (52 papers), MicroRNA in disease regulation (22 papers) and Drug Transport and Resistance Mechanisms (17 papers). Glen Reid collaborates with scholars based in Australia, New Zealand and Netherlands. Glen Reid's co-authors include Nico van Zandwijk, Michaela B. Kirschner, Piet Borst, Noam Zelcer, Peter R. Wielinga, Steven Kao, Jan Wijnholds, J. James Edelman, Michael P. Vallely and Ingrid van der Heijden and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Glen Reid

109 papers receiving 7.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Potent and specific inhibition of the breast cancer resistance protein multidrug transporter in vitro and in mouse intestine by a novel analogue of fumitremorgin C.

2002 590 citations Glen Reid et al. PubMed profile →
Safety and activity of microRNA-loaded minicells in patients with recurrent malignant pleural mesothelioma: a first-in-man, phase 1, open-label, dose-escalation study

2017 539 citations Nico van Zandwijk, Anthony Linton et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Glen Reid Australia	40	3.4k	2.7k	2.2k	1.2k	943	110	7.1k
Takeshi Uchiumi Japan	55	5.6k 1.6×	3.2k 1.2×	1.1k 0.5×	924 0.8×	934 1.0×	201	9.1k
Thomas Litman Denmark	46	4.0k 1.2×	4.5k 1.7×	1.4k 0.6×	300 0.2×	1.5k 1.6×	146	8.5k
Mario Strazzabosco Italy	52	1.7k 0.5×	2.2k 0.8×	778 0.3×	1.2k 0.9×	274 0.3×	226	8.4k
Eiso Hiyama Japan	41	4.0k 1.2×	1.8k 0.7×	1.3k 0.6×	800 0.7×	222 0.2×	230	8.8k
Federico Canzian Germany	46	3.2k 0.9×	2.3k 0.8×	1.8k 0.8×	583 0.5×	107 0.1×	147	7.2k
Katsuhiko Nosho United States	55	4.1k 1.2×	4.6k 1.7×	2.2k 1.0×	1.4k 1.1×	109 0.1×	112	9.0k
Yutaka Kohgo Japan	44	2.9k 0.8×	1.4k 0.5×	1.0k 0.5×	572 0.5×	123 0.1×	243	7.4k
Lin Zhou China	38	1.9k 0.5×	1.2k 0.5×	840 0.4×	291 0.2×	321 0.3×	149	4.1k
Kevin M. Ryan United Kingdom	53	7.3k 2.1×	3.0k 1.1×	2.3k 1.1×	610 0.5×	75 0.1×	115	11.8k
Naoko Ohtani Japan	40	4.6k 1.3×	1.6k 0.6×	913 0.4×	389 0.3×	118 0.1×	76	8.3k

Countries citing papers authored by Glen Reid

Since Specialization

Citations

This map shows the geographic impact of Glen Reid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Glen Reid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Glen Reid more than expected).

Fields of papers citing papers by Glen Reid

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Glen Reid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Glen Reid. The network helps show where Glen Reid may publish in the future.

Co-authorship network of co-authors of Glen Reid

This figure shows the co-authorship network connecting the top 25 collaborators of Glen Reid. A scholar is included among the top collaborators of Glen Reid based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Glen Reid. Glen Reid is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Schelch, Karin, Dominik Kirchhofer, Gerald Timelthaler, et al.. (2025). Inhibition of YB-1 phosphorylation enhances cisplatin activity and disrupts cell division in pleural mesothelioma. British Journal of Cancer. 133(9). 1391–1400.

Drummond, Catherine J., et al.. (2024). The Potential Links between lncRNAs and Drug Tolerance in Lung Adenocarcinoma. Genes. 15(7). 906–906. 1 indexed citations

Ahmadzada, Tamkin, Fatemeh Vafaee, Glen Reid, et al.. (2023). Small and Large Extracellular Vesicles Derived from Pleural Mesothelioma Cell Lines Offer Biomarker Potential. Cancers. 15(8). 2364–2364. 8 indexed citations

Schelch, Karin, Thomas G. Johnson, Verena Kopatz, et al.. (2023). Targeting YB-1 via entinostat enhances cisplatin sensitivity of pleural mesothelioma in vitro and in vivo. Cancer Letters. 574. 216395–216395. 12 indexed citations

Ratajska, Magdalena, George A. R. Wiggins, Bożena Cybulska-Stopa, et al.. (2021). Differential Expression of BARD1 Isoforms in Melanoma. Genes. 12(2). 320–320. 4 indexed citations

Ahmadzada, Tamkin, Kenneth Lee, Candice Clarke, et al.. (2019). High BIN1 expression has a favorable prognosis in malignant pleural mesothelioma and is associated with tumor infiltrating lymphocytes. Lung Cancer. 130. 35–41. 17 indexed citations

Cheng, Yuen Yee, et al.. (2017). OA02.05 Expression of miR-223 in Mesothelioma Xenografts Originates from Stromal Cells in the Tumor Microenvironment. Journal of Thoracic Oncology. 12(1). S248–S248. 1 indexed citations

Schelch, Karin, Michaela B. Kirschner, Marissa Williams, et al.. (2017). OA02.01 The microRNA-15/16 Family Regulates Tumor Cell Growth via Fibroblast Growth Factor Signals in Malignant Pleural Mesothelioma. Journal of Thoracic Oncology. 12(1). S246–S246. 2 indexed citations

Cheng, Ngan Ching, Nico van Zandwijk, & Glen Reid. (2014). Cilengitide Inhibits Attachment and Invasion of Malignant Pleural Mesothelioma Cells through Antagonism of Integrins αvβ3 and αvβ5. PLoS ONE. 9(3). e90374–e90374. 27 indexed citations

10.

Wright, Casey M., Michaela B. Kirschner, Yuen Yee Cheng, et al.. (2013). Long Non Coding RNAs (lncRNAs) Are Dysregulated in Malignant Pleural Mesothelioma (MPM). PLoS ONE. 8(8). e70940–e70940. 2 indexed citations

11.

Kirschner, Michaela B., et al.. (2013). The Impact of Hemolysis on Cell-Free microRNA Biomarkers. Frontiers in Genetics. 4. 94–94. 285 indexed citations

12.

Kirschner, Michaela B., Yuen Yee Cheng, Steven Kao, et al.. (2012). Increased circulating miR-625-3p. Murdoch Research Repository (Murdoch University). 1 indexed citations

13.

Kirschner, Michaela B., Yuen Yee Cheng, Steven Kao, et al.. (2012). Increased Circulating miR-625-3p: A Potential Biomarker for Patients With Malignant Pleural Mesothelioma. Journal of Thoracic Oncology. 7(7). 1184–1191. 94 indexed citations

14.

Wielinga, Peter R., Jan Hendrik Hooijberg, Ietje Kathmann, et al.. (2005). The Human Multidrug Resistance Protein MRP5 Transports Folates and Can Mediate Cellular Resistance against Antifolates. Cancer Research. 65(10). 4425–4430. 107 indexed citations

15.

Cochran, Clarke E., et al.. (2003). Protecting Texas children: evidence-based recommendations for improving childhood vaccination rates.. PubMed. 99(3). 52–60. 4 indexed citations

16.

Zelcer, Noam, Glen Reid, Peter R. Wielinga, et al.. (2003). Steroid and bile acid conjugates are substrates of human multidrug-resistance protein (MRP) 4 (ATP-binding cassette C4). Biochemical Journal. 371(2). 361–367. 245 indexed citations

17.

Reid, Glen, Peter R. Wielinga, Noam Zelcer, et al.. (2003). Characterization of the Transport of Nucleoside Analog Drugs by the Human Multidrug Resistance Proteins MRP4 and MRP5. Molecular Pharmacology. 63(5). 1094–1103. 300 indexed citations

18.

Wolff, Natascha A., N Kuhnke, Glen Reid, et al.. (2003). Protein Kinase C Activation Downregulates Human Organic Anion Transporter 1-Mediated Transport through Carrier Internalization. Journal of the American Society of Nephrology. 14(8). 1959–1968. 69 indexed citations

19.

Wielinga, Peter R., Glen Reid, Ingrid van der Heijden, et al.. (2002). Thiopurine Metabolism and Identification of the Thiopurine Metabolites Transported by MRP4 and MRP5 Overexpressed in Human Embryonic Kidney Cells. Molecular Pharmacology. 62(6). 1321–1331. 149 indexed citations

20.

Zelcer, Noam, Tohru SAEKI, Glen Reid, Jos H. Beijnen, & Piet Borst. (2001). Characterization of Drug Transport by the Human Multidrug Resistance Protein 3 (ABCC3). Journal of Biological Chemistry. 276(49). 46400–46407. 206 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact